NHS 加快推广首个靶向肛门癌治疗
Patients living with advanced anal cancer can now benefit from a new life-extending treatment.
患有晚期肛门癌的患者现在可以受益于一种新的延长生存期的治疗。 这一决定基于一项临床试验,试验发现接受该治疗的患者平均比仅接受化疗的患者多活 11 个月。 ➡️ https://www.england.nhs.uk/2026/11/nhs-fast-tracks-rollout-of-first-ever-targeted-treatment-for-anal-cancer/
